MPG.eBooks - Search Results - "cells"

Cover Image

1

Pharmacoeconomic review report: Tocilizumab (Actemra) (Hoffman-La Roche Limited)

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Giant Cell Arteritis / drug therapy...”

Cover Image

2

Pharmacoeconomic review report: Tocilizumab (Actemra) (Hoffman-La Roche Limited)

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Giant Cell Arteritis / drug therapy...”

Cover Image

3

CADTH Canadian Drug Expert Committee recommendation: Tocilizumab (Actemra - Hoffmann-La Roche Limited) : indication : giant cell arteritis

Published 2018

CADTH

Subjects: “...Giant Cell Arteritis / drug therapy...”

Cover Image

4

CADTH Canadian Drug Expert Committee recommendation: Tocilizumab (Actemra - Hoffmann-La Roche Limited) : indication : giant cell arteritis

Published 2018

CADTH

Subjects: “...Giant Cell Arteritis / drug therapy...”

Cover Image

5

Pharmacoeconomic review report: Letermovir (Prevymis) (Merck Canada Inc.)

Published 2018

CADTH

Subjects: “...Hematopoietic Stem Cell Transplantation...”

Cover Image

6

Pharmacoeconomic review report: Letermovir (Prevymis) (Merck Canada Inc.)

Published 2018

CADTH

Subjects: “...Hematopoietic Stem Cell Transplantation...”

Cover Image

7

Axicabtagene ciloleucel for diffuse large B-cell lymphoma: Economic review report

Published 2019

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Lymphoma, Large B-Cell, Diffuse / drug therapy...”